Stay Informed


Considering treatment for relapsing multiple sclerosis (MS)?
You′re bound to have questions.

Sign up to receive information about
  • How in clinical trials GILENYA® cut MS relapses, slowed disability progression, and reduced the average number of lesions as seen on magnetic resonance imaging (MRI)
  • Preparing to talk to your health care professional
  • Getting started on GILENYA
  • The side effects of GILENYA
  • How to find out whether you qualify for a $0 prescription co-pay*
  • How to get involved with the GILENYA community

All fields are required unless otherwise noted.


Don't be shy. We would love to learn a little more about you. To continue, you'll need to complete or correct the following field(s):

  • Year of Birth
  • First Name
  • Last Name
  • E-mail
  • Address 1
  • City
  • State
  • ZIP Code
  • Gender


In which year were you born?

Must be 18 years or older

Are you currently taking GILENYA?


If not on GILENYA, what type of therapy are you taking? (optional)

When were you diagnosed with relapsing MS? (optional)


CorrectAddress Error

Please enter a valid e-mail address. (Don't forget the @)

CorrectAddress Error
CorrectAddress Error

We're not sure where that ZIP code is!



I agree to the Privacy Terms as outlined in the Novartis Privacy Policy.

I also agree to receive marketing information and to be contacted for my opinions about multiple sclerosis (MS) products, programs, and services.

You can cancel your participation at any time by calling 1-888-669-6682 or by using the unsubscribe link in our e-mails.

*In 2015, most eligible patients paid a $0 co-pay. Call 1-800-GILENYA for details. People for whom GILENYA has been prescribed are required to report any benefits they receive through the GILENYA Prescription Co-Pay Support Program to their commercial insurance company. Limitations apply. Valid only for those with commercial insurance. Offer not valid under Medicare, Medicaid or any federal or state program. Not valid for cash-paying patients, where product is not covered by patient's commercial insurance, or where plan reimburses you for entire cost of your prescription drug. Offer is not valid where prohibited by law. Valid only in the US and Puerto Rico. This program is not health insurance. Offer may not be combined with any other rebate, coupon, or offer. This program is subject to termination or modification at any time.

GILENYA can result in a slow heart rate when first taken. You will be observed by a health care professional for at least 6 hours after you take your first dose. You may need to repeat this monitoring if you miss a dose.


Are you ready for one pill, once a day*? Get tips for talking to your doctor about GILENYA.



What sets GILENYA apart? It's all in the details: see GILENYA in action.


Real people taking GILENYA discover a community of support

Novartis ISI Novartis ISI
Novartis ISI
Novartis ISI

Speak up and share your message. Tell multiple sclerosis (MS) how you really feel by posting your message on our "HEY MS" message board.

Make sure your voice is heard. We love that you want to say "Take This!" to relapsing MS, but there are still some words even we can't use—words that might not be appropriate. They're defined in the Community Guidelines below. But have no fear; we'll give you a heads up if you use any problematic words by highlighting them after you hit submit. So, go for it, and tell relapsing MS how you really feel!

  • Do not include medical advice or any non-approved use of GILENYA

  • No profane, indecent, or inappropriate language in your message or image, please (a no-no)

  • Avoid using your full name and/or e-mail address in your message, so this personal information remains private and protected

  • Do not include spam, such as links to or URLs for other websites or social networks in your message

  • Refrain from sharing any treatment and/or dosage information, as well as names of specific medicines (brand name or generic) and product manufacturers

  • Avoid mention of side effects from GILENYA. We take drug product safety seriously. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call

Please note that in order to comply with our Community Guidelines as well as the FDA's Prescription Drug Advertising Guidelines, your statement may be subject to modification, while maintaining the spirit of your message. Your photo and statement may be used in other GILENYA marketing materials